Fintel reports that on October 1, 2024, Citigroup upgraded their outlook for Bio-Rad Laboratories (NYSE:BIO) from Neutral to ...

Citi upgrades Bio-Rad Laboratories (BIO) to buy, downgrades Hologic (HOLX) to neutral and Charles River Laboratories (CRL) to ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $378.4, a high ...

With a market cap of $9.5 billion, Bio-Rad Laboratories, Inc. (BIO) operates in the healthcare and life sciences industry.

Bio-Rad Laboratories is buying back a considerable amount of its own stock given the current valuation and growth prospects.

Asthma is a health condition that affects the respiratory system. “Reactive airway disease (RAD)” is a more general term for a respiratory condition that causes wheezing or breathing issues.

The project, to be completed within 18 months, aligns with India’s National Green Hydrogen Mission and marks a significant step towards sustainable energy. Gensol and Matrix have partnered with ...

He said that bio-manufacturing offers solutions to global challenges like climate change, resource depletion, waste generation, and pollution. Union Minister Jitendra Singh said on Saturday that ...

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Jon DiVincenzo ...

Biotech tackles climate change with innovations, from carbon-neutral facilities to reducing emissions. At COP28, BIO highlighted that biotech is key to climate tech. Since Watson and Crick discovered ...

Data supplied by Morningstar and accurate on Sep 14, 2023. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...